A Blockbuster Drug Lyrica truly merits the description ‘blockbuster drug’. FDA approved for seizures, neuropathic pain, fibromyalgia (2007), and generalized anxiety disorder (Europe), Lyrica (pregabalin) sales hit their peak in the last quarter in the US, bringing in over $550 million for Pfizer. Lyrica’s success – despite issues with side … Continue reading The Lyrica Effect: Lyrica Study Uncovers Key Brain Abnormalities in Fibromyalgia